Share

    


Home / Search Results

Search Results

Search Publications

Search Again?

Filter By Topic

You searched for:

In recognition of Bladder Cancer Awareness Month, ACCC would like to stress the importance of reducing existing disparities in bladder cancer care.
ACCC is supporting the Improving Seniors’ Timely Access to Care Act of 2021, which would require Medicare Advantage plans to standardize and streamline prior authorization processes and increase the transparency of their requirements to prevent unnecessary denials and delays in patient care.
ACCC recently partnered with Hallmark Health Care Solutions to host a live broadcast, where expert panelists discussed barriers and effective practices to ensure the recruitment and retainment of a quality workforce.
May celebrates Oncology Nursing Month, and ACCC recognizes the integral role oncology nurses play in cancer care delivery.
Ahead of this year's Prescription Drug User Fee Act (PDUFA) reauthorization, ACCC and 88 other patient and provider advocacy organizations urged congressional leadership to pass legislation that would improve the diversity of enrollment in clinical trials. The letter expresses support for a number of policy proposals, including provisions from the DIVERSE Trials Act (H.R. 5030/S. 2706) and the DEPICT …
The final post in a three-blog series, ACCCBuzz spoke to Megan Morava, PA-C, and Alexandra Greenawalt who share how one independent oncology practice and local community center are taking action to improve equitable cancer care delivery at the local level.
ACCC joined more than 400 organization from all 50 states to urge Congress to pass the Medicare Multi-Cancer Early Detection (MCED) Screening Coverage Act (H.R.1946/S.1873) this year. This legislation would create a pathway for MCED tests to be covered by the Medicare program following approval by the Food and Drug Administration (FDA). Read the Letter
Testing for measurable residual disease can shape treatment choices and patient management to achieve better outcomes, and the need persists for members of the multidisciplinary cancer care team to better understand the purpose, use, and significance of this testing in all cancer treatment settings.
Technology has a key role to play in the future of cancer care delivery. Read how artificial intelligence (AI) is being used to help cancer programs and practices stay financially viable, while offering high-quality care.
The second post in a three-blog series, ACCCBuzz shares how Carolina Blood and Cancer Care Associates' NOLA initiative is addressing access to care, clinical trials, biomarker testing, and more.
This blog is the first in a two-part series on value-based care transformation, focusing on new site of care settings like patients' homes.
Carolina Blood and Cancer Care Associate's No One Left Alone (or NOLA) initiative is a multi-phase pilot program aimed at lessening disparities in cancer care in three key areas: care access, biomarker testing, and clinical trials.
ACCC—which has made mitigating disparities in cancer care a core component of its mission—recognizes the importance of National Minority Health Month and National Minority Cancer Awareness Week this April.
This is the first post in an ACCCBuzz series on effective leadership practices in cancer care, written by Dr. Barbara Schmidtman.
The letter asks Congress to increase funding for this program from $20 to $60 million to approximate the level of support necessary to fund high-quality research applications and to ensure that funding is commensurate with the impact of deaths attributable to lung cancer among Veterans Health Administration patients.
The US has seen a steady decline in the overall incidence of colorectal cancer (CRC) during the past several decades. In 1975, 60 people per 100,000 were diagnosed with colorectal cancer; by 2018, that number had fallen to 34. But overall trends in CRC incidence and outcomes often differ among racial groups and geographic locations. Black Americans are more likely to be diagnosed with CRC than White …
In response to a Senate Finance Committee Hearing entitled "Prescription Drug Price Inflation: An Urgent Need to Lower Drug Prices in Medicare", ACCC submitted a statement for the record highlighting concerns with proposed drug pricing legislation.
Jeanie Troy, a financial navigator at Lake Region Healthcare in the Cancer Care and Research Center, discusses how to help uninsured patients access their anti-cancer treatment if they are not eligible for Medicare or Medicaid.
March is Multiple Myeloma Awareness Month. Learn how ACCC is supporting collaboration among healthcare providers with practical, scalable solutions to the real-world challenges of improving quality care delivery for patients with multiple myeloma.
After convening its members, sponsors, and industry partners in Washington, DC, for the first time since the dawn of COVID-19, ACCC Buzz shares a glimpse of the activities and insights the final day at ACCC’s 48th Annual Meeting and Cancer Center Business Summit.